Through the concept of Pharmacognosy, we recognize the real value - the hidden treasure or the hidden path - towards the best understanding of existence in all its assemble.
Pharmacognosy is derived from the Greek terms - φάρμακον pharmakon (drug), and γνῶσις gnosis (knowledge).
Historical accounts give different interpretations, which are nonetheless true. Still, we want to emphasize a remarkable statement of Paracelsian origin, which says that Signatures signify the knowledge of the inherent essence based on the external arrangement.
"Thou shalt know all
internal characteristics by looking at the outside."
Astronomica Magna: "By the signs, whether it is a plant, a tree, a living entity, or an inanimate object, the specialist will learn how to perceive the essence of all objects."
He refers to nature as God intended, and He left us with signs to discover the values He concealed in all creation.
"God does not want things to stay hidden, which He created for humanity's benefit and which He gave a man as his property into his hand. . . and even though He hid it, so did He mark upon it outward, visible signs, that are distinctive marks."
The Ancients thought that everything was linked to nature and to the universe and comprised of the four elements (fire, earth, air, water) and dual-energy (male, female, yin, and yang).
It was also thought that a particular planet could exert its influence over a specific thing that in their secret relationship, it corresponds to its aspects, and hence, it affected all its attributes.
The human body was seen as a miniature reproduction of our solar system with a symbolic representation of a sign and planet for each body part arrangement.
Through observing what condition a plant was usefully intended, planetary and elemental correspondences were established, detailing it as an aspect of herbal medicine within "Doctrine of Signatures" or "Signatura Rerum" paragraphs.
The Theory of Signatures is a theory taught by herbalists from the time of Dioscurides (c. 40-90 AD) which suggests that each plant has a pattern that resembles a body organ or physiological feature and that these patterns serve as a warning or as a sign of the plant's benefit.
Many European intellectuals in the 16th century were drawn to the Signature Doctrine The most well-known among them was perhaps Theophrastus Bombast von Hohenheim (1493-1541), colloquially known as Paracelsus.
The definition was developed and written by Paracelsus in his writings.
Paracelsus (1493/4 – 24 September 1541), born Theophrastus von Hohenheim (full name Philippus Aureolus Theophrastus Bombastus von Hohenheim
The "law of similes" applied to herbology by Paracelsus means that the specific characteristic of the plant will cure a similar thing in the consciousness or body.
This is yet another way of talking about the parallel found in the Doctrine of Signatures.
Jakob Böhme's writings (1575–1624) introduced the Doctrine of Signatures
Böhme claimed that God marked things throughout their function with a specific symbol, or "signature."
A plant bearing components that resembled human body parts, humans, or other things are considered to be relevant to those parts, species, or things/entities.
Paracelsus saw a substance's innermost essence or essential properties as something similar to a secret, hence an arcana.
It wasn't secret in the sense that something wasn't told, but mysterious, beyond words.
Like his contemporaries, he did not believe in comparing correspondences rationally or analytically, such as fixing a human's right eye with an animal's right eye.
The supposition didn't serve as a foundation for Paracelsus because it wasn't magical, not in line with natural magic, and this beyond-rational magic of healing with natural substances meant that a flower with a luminous appearance like Eyebright, something that wasn't an eye but similar to an eye, would heal the eyes as if by magic — Eyebright is one of the most effective remedies for conjunctivitis.
In his opus Phytognomonica created in the year 1588, Jakob Bohme (1575–1624) tracked the copy of Giambattista Porta, broadening this concept through written work, and actively promoting that God would mark things with a sign or "signature" for their utilization.
It was assumed that plants, animals, or other objects with parts similar to human organs had functional significance to those parts. In the habitats or specific places where plants grow, the unique characteristic "signature" could also be recognized on occasions.
Bohme's book "Signatura Rerum; The Signature of All Things" published in early 1600 gave the name to this Doctrine. Originally, the book pursued a spiritual philosophy but was then approved for medical purposes.
The botanist William Coles (1626–1662) supposed that God has made "Herbs for the use of men and has given them particular Signatures, whereby a man may read the use of them."
"Coles '" Art of Simpling "and" Adam in Eden "believed that walnuts are excellent at curing head/brain disorders because, in his view," they have the ideal Signatures that resemble the human brain.
A philosophical reason for this was that "God would have wanted to show people what plants would be useful for." Hypericum wrote, "The little holes of which the leaves of Saint John's wort are full emulate all the pores of the skin and therefore it is beneficial for all the hurts and wounds that may occur thereunto."
"In The Order of Things, Michel Foucault says:" ... Of course, there must be a sign that will make us aware of these things: otherwise the secret will remain dormant virtually forever.
Tippo and Stern were of the opinion that "In many instances, a firm belief in the goodness of God who put everything on earth to his people gave rise to the Signature Theory, which held that the secret to man's use of plants was concealed in the shape of the plant itself; one had only to look closely at it."
Some modern scholars claim the theory came from Egypt, while others argue that it originated in China and Europe during the Middle Ages.
William Balee suggested that the Signature Doctrine is: ' Universal since similar patterns of ' resemblance ' were observed in ancient Asia, Classical Greece, medieval Europe, and pre-Columbian America. ' Walter Pagel, who studied Paracelsus ' writing, described the Signature Doctrine as ' A form of medicine that directs it to the appropriate place of action without further guidance.
For nature has sculpted this shape from formless ' primary matter ' through its ' alchemy, ' turning it into ' ultimate ' matter with a particular ' form '
There are traces of the influence of the Doctrine of Signatures among the doctors from Orient, especially in the Ottoman period.
The major historical sources are chronologically listed below.
Jewish physician, (about 6-9th century CE). His book on medicine contains essential medical and pharmacological data.
Among the most important muslim physicists (980-1037 CE), is widely remembered for his book The Canon.
Reputedly known as Maimonides/
Rabbi Moshe ben Maimon (1135-1204) was a Jewish physician in Egypt, where he was the Sultan's physician.
Ḍiyāʾ Al-Dīn Abū Muḥammad ʿAbdllāh Ibn Aḥmad al-Mālaqī, commonly known as Ibn al-Bayṭār (1197–1248 AD)
Andalusian physician and herbalist, who visited the Near East. His main book
The Compendium of Simple Drugs and the Food
Qazwini was a physician, astronomer, geographer and writer of Arab descent.
He was very much interested in the natural sciences. He has written a book called Marvels of Things Created and Miraculous Aspects of Things Existing (13th century).
He was a blind Syrian Christian physician and pharmacist active in Cairo, who died in 1599.
A well-known physician and writer of treatises on medicine.
Very few books have been written based on the doctrine of signatures. The works of Paracelsus are based on signatures, but he was more interested in minerals than plants, so we don't obtain much practical understanding from his works, just signature philosophy.
In the seventeenth century, the first practical texts appeared in Latin, including Phytonomincon by Giambattista della Porta and a study by Oswald Crollius. The first signature book in English is Adam in Eden, released in London by William Coles, "at the Angel in Cornhill," in 1657.
Coles describes the technique by which he plans to "find the very Pith and Marrow of Herbalism with all kinds of individuals," namely:
I have made an Anatomical application throughout the Series of the whole work, by appropriating to every part of the Body (from the Crown of the Head, with which I begin; and proceed till I come to the Soul of the Foot) such Herbs and Plants, whose grand uses and virtues do most specifically, and by Signature, thereunto belong; not only for strengthening the Same, but also for curing the evill Affects whereunto they are subjected.
One time I read in Adam and Eden that sage was suitable for skin conditions that looked like wrinkled like sage leaf. "Oh, ridiculous," I thought to myself.
Six months later, I had a case just like that and couldn't think of anything except sage. Presto, it worked perfectly, and has always worked on what is called 'lichenification' in dermatology -the skin looks like a sage leaf. This is particularly common in woman and sometimes men, in the decline of life, from the fifties onwards, when the vital juices are drying out. That is where sage is most remedial.
Ben Charles Harris, a pharmacist in Wooster, Massachusetts, who passed away several decades ago, was one of the few late-twentieth-century authors who used signature doctrine. He provides a label for every use of each crop in The Compleat Herbal (1972).
Some are magic, but some are feasible. Even though he was a scientist — a pharmacist — Harris was a forest man from New England who understood what the crops looked like, where they originated, and the overall legitimacy of the signature doctrine.
Again and again we do find countless examples of medicinal herbs on which are "stamped" an indication of their healing properties. The inquisitive novice herbalist need only apply his powers of observation to evaluate clues to the herbs' therapeutic powers, the remedial qualities, or the diseases for which these qualities are indicated.
If at times the examples of correspondences throughout this work appear far-fetched, let me offer as warrants of the doctrine's usefulness some fifty-five years of living with and experiencing the healing herbs, as well as close to four decades of professional pharmacy and teaching of herbalism (Harris, 1972).
Harris (1972) also stresses that the doctrine of signatures is a good memory device.
Instead of tedious memorization of a plant's multiple uses, the signature doctrine provides a secure method of linking the herb with its therapeutic use through the symbolic connection in many (although not all) instances.
In traditional herbalism, particularly before the advent of writing, the use of signatures often passed on herbal knowledge to help the student understand the plant's logic and remember its use.
Michel Foucault described it in his The Order of Things:
".. .there must, of course, be some mark that will make us aware of these things: otherwise, the secret would remain indefinitely dormant".
Tippo and Stern stated:
that "In many cases, a firm belief in the goodness of God who put everything on earth for his people gave rise to the Doctrine of Signatures which held that the key to man's use of plants was hidden in the form of the plant itself; one had only to look closely".
William Balee suggested that the Doctrine of Signatures is: "universal since similar patterns of 'resemblance' have been observed in ancient Asia, Classical Greece, medieval Europe, and pre-Columbian America."
Tamsyn Barton asserted that: "The idea of 'sympathy'... together with its corollary 'antipathy' was implicit in a wide variety of ancient writer, particularly in the field of medicine. It is related to the idea of correspondence, which designated animals, plants, and stones as sympathetic or antipathetic to particular conditions, which might or might not be seen to be caused by the heavenly bodies."
A plant bearing parts that resembled human body-parts, animals, or other objects were thought to have useful relevance to those parts, animals or objects.
The "signature" may also be identified in the environments or specific sites in which plants grew.
Well-known examples include the following:
1/3
Facts & Future
PHARMACOGNOSY: FACTS AND FUTURE
A.Divya*
Department of Pharmaceutics, Ratnam Institute of Pharmacy, Nellore
The history of herbal medicine is as recent as human civilization. Herbal medicines as a significant remedy in the ancient systems of medicine are employed in medical practices since antiquity [3]. The documents, many of which are of great antiquity, unconcealed that plants were used medicinally in China, India, Egypt, and Greece long before the beginning of the common era. One amongst the foremost notable living remnants is papyrus Ebers, sixty feet long and a foot wide that might be a sixteenth xerophile BC [4-8]. - (from Greek xēros, meaning ' dry ' and philos, meaning ' loving ') is an extremophilic organism capable of growing and reproducing under conditions with low water accessibility, also known as
water activity.)
Pharmacognosy will be outlined because of the science of biogenic or naturally derived medication, prescription drugs, and poisons, and it incorporates varied fashionable analytical techniques to evidence and internal control of crude medicine besides as pure active extracts, fractions, and elements, and even healthful foods [9-13]. Drug use from nutritious plants has advanced from the formulation of crude medication to the isolation, identification, and assessment of bioactivity of active compounds in drug discovery [14,15]. Pharmacognosy involves the broad study of
natural products from varied sources together with plants, bacteria, fungi, and marine organisms. Asian nation flavoring medicines are the bases of treatment and cure for diverse diseases in ancient strategies like Ayurveda, Unani, and Sidha [16-21].
In Asian countries, particularly for the agricultural population, flavoring medication acquires the first selection for treatment [22]. The World Health Organization (WHO) estimates that eighty percent of the population of some Asian and African countries presently uses flavoring medicines for a few sides of primary health care [23-30]
Pharmacognosy, which accurately means that finding out medications of natural sources, has been a district of healing arts and sciences since humankind initiate to treat sicknesses [31-33]. To induce a correct perspective concerning this science that deals with plant-animal, mineral, and different natural medications, it's advantageous to research the historical aspects of this science and to acknowledge the pioneers of this field [34-40].
FACTS
During the past 50 years, there is advancement in the chemical and biological techniques of analysis that have transformed research in pharmacognosy. Natural medicines are accustomed to enhance human and veterinary health since past times, and also the success of modern life science mostly depends on medication initially obtained from natural resources [41-50].
The conventional medical practices adopted for identification and authentication of natural remedies eventually framed the Botanico-chemical approach to Pharmacognosy throughout the 19th century. However, the last 200 years witnessed a considerable metamorphosis within the principles and practices of Pharmacognosy, and it's become a vital domain of recent pharmaceutical science as a multidisciplinary high-tech science of natural medicines. In a very modern context, the systematic study of natural drugs in terms of purity, potency, consistency, and safety became
the first problems in Pharmacognosy [51-56]. Moreover, most of the current day's drug discoveries are progressively adopting ancient medication based mostly approaches to extend results and to handle safety issues. Thus, Clinical Pharmacognosy, Analytical Pharmacognosy, and Industrial Pharmacognosy are established as a specialized and skilled offshoots of Pharmacognosy to fulfill the modern advancements within the field of Pharmacognosy [57-65].
SCOPE
Plant species could also be taken into account as a synthesis and for the chemical compounds example proteins, carbohydrates, and fats that square measure used as food by the animals and humans, however additionally for an enormous range of compounds as well as alkaloids, terpenoids, flavonoids, glycosides, etc. that exert definite physiological effects. These chemical compounds square measure principally answerable for the required useful properties [66-70].
PC has additionally seen plenty of ups and downs driven by the expansion of pharmaceutical business, dynamical client habits and wishes, and up to date client movement toward the employment of natural materials. Pharmacognosy has played a crucial role within the discovery and development of the latest medication and therapies and has been continued to try and do thus even these days. It additionally shaped the idea of the event of the topic "Pharmacy” [71-76].
The herbal medication have gained importance in recent years because of their effectuality and cost-effectiveness. The systematic study of flavorer remedies offers pharmacognosy teams a lovely new space of analysis, starting from work the biologically active principles of phytomedicines and their mode of action and potential drug interactions, to internal control, and involvement in clinical trials. Fashionable assemblage still contains a minimum of the twenty-fifth medication derived from plants and lots of others that are artificial analogs engineered on paradigm compounds isolated from plants [77-81].
Prevalence is unceasingly increasing in each developing and developed countries as a result of their natural origin and lesser facet effects. Currently a day’s drug discovery from medicative plants involves a multiple approach of biology, phytochemical, biological, and molecular techniques. Drug discovery from medicative plants gives new and necessary leads against numerous medicine targets together with cancer, HIV or AIDS, Alzheimer's, malaria, and pain. Much natural product medications of plant origin have either recently been introduced are presently concerned in
late-phase clinical trials [82-87].
Pharmacognosy isn't an issue of the past, however its evolved and developed over the years to adapt itself with the ever-changing surroundings, and is currently appropriate meet the challenges of the current and also the way forward for drug discovery and development.
Thus, the importance of Pharmacognosy in Pharmacy cannot be overemphasized.
e-ISSN: 2321-6182
p-ISSN: 2347-2332
Research and Reviews: Journal of Pharmacognosy and
Phytochemistry
PHARMACOGNOSY: FACTS AND FUTURE
A.Divya*
Department of Pharmaceutics, Ratnam Institute of Pharmacy, Nellore
Received: 16/05/2015
Accepted: 23/05/2015
Published: 30/05/2015
*For Correspondence
Department of Pharmaceutics, Ratnam Institute of Pharmacy, Nellore.
E-mail: Divyapharma15@gmail.com.
References:
1. UNESCO. Culture and Health. Orientation Texts- World Decade for Cultural Development 1988-1997. Paris, France. 1996
2. UNESCO Terminal Report: Promotion of Ethnobotany and the Sustainable Use of Plant Resources in Africa. Paris, France. 1998
3. Ibrahim Singab ANB. Medicinal & Aromatic Plants. Medicinal Aromatic Plants. 2012; 1:e109.
4. Berger M. Traditional medicine: a clear and present danger? South African J Sci 2006;102: 178-179.
5. Huffman MA. Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proc Nutr Soc. 2003; 62: 371-381.
6. Kuete V and Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol. 2010;1: 123.
7. Kuete V, Ngameni B et al. Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus dorstenia: gancaonin q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol. Planta Med. 2011; 77: 1984-1989.
8. Kuete V, Wiench B et al. Antibacterial Activity and Cytotoxicity of Selected Egyptian Medicinal Plants. Planta Med. 2011.
9. Efferth T, Miyachi H and Bartsch H. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy. Cancer Genomics Proteomics. 2007a; 4: 81-91.
10. Efferth T. Pharmaceutical biology of traditional Chinese medicine for cancer therapy. In: M Eddouks (Ed.). Handbook of Ethnopharmacology, Research Signpost, Kerala, India. 2008.
11. Konkimalla VB and Efferth T. Molecular mechanisms and interactions responsible for radio- and
chemoresistance of tumors and their modulation by natural products from Ayurveda In: R. Arora (Ed.) Herbal medicine. A cancer chemopreventive and therapeutic perspective. Jaypee Brothers Medical Publishers Pvt. Ltd, New Delhi, St. Louis (USA). 2010.
12. Sudakin DL. Biopesticides. Toxicol Rev. 2003; 22: 83-90.
13. Raskin I and Ripoll C. Can an apple a day keep the doctor away? Curr Pharm Des. 2004; 10: 3419-3429.
14. Saklani A and Kutty SK. Plant-derived compounds in clinical trials. Drug Discov Today. 2008;13: 161-171.
15. Efferth T and Koch E (2011) Complex interactions between phytochemicals. The multi-target therapeutic
concept of phytotherapy. Curr Drug Targets 12: 122-132.
16. Van Wyk BE, Wink M. Medicinal plants of the world. Pretoria, Briza. 2004.
17. Wagner H and Ulrich-Merzenich G. Synergy research: approaching a new generation of
phytopharmaceuticals. Phytomedicine. 2009; 16: 97-110.
18. Sertel S, Fu Y et al. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric
precursors, vindoline and catharanthine. Biochem Pharmacol. 2011; 81: 723-735.
19. Li JWH and Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science.
2009; 325: 161-165.
20. Koehn FE and Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005; 4: 206-220.
21. Newman DJ and Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007; 70: 461-477.
22. Schmidt BM, Ribnicky DM, Lipsky PE and Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol. 2007; 3: 360-366.
23. Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets. 2006; 7: 407-421.
24. Efferth T, Fu YJ, et al. Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Curr Med Chem. 2007; 14: 2024-2032.
25. Efferth T, Li PC, Konkimalla VS and Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007; 13: 353-361.
26. Romero MR, Serrano MA, Efferth T, Alvarez M and Marin JJ. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication. Planta Med. 2007; 73: 552-558.
27. Fu Y, Li S, et al. Medicinal chemistry of paclitaxel and its analogues. Curr Med Chem. 2009; 16: 3966-3985.
28. Efferth T. Cancer therapy with natural products and medicinal plants. Planta Med. 2010; 76: 1035-1036.
29. Efferth T. Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products. Planta Med. 2010; 76: 1143-1154.
30. Mahady GB. Global harmonization of herbal health claims. J Nutr. 2001; 131: 1120S-1123S.
31. Waters MD and Fostel JM. Toxicogenomics and systems toxicology: aims and prospects. Nat Rev Genet. 2004; 5: 936-948.
32. Youns M, Hoheisel JD and Efferth T. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Planta Med. 2010; 76: 2019-2025.
33. Efferth Tand Kaina B. Toxicity of the antimalarial artemisinin and its derivatives. Crit Rev Toxicol. 2010; 40: 405-421.
34. Efferth Tand Kaina B. Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab. 2011; 12: 989-996.
35. Eichhorn T, Greten HJ and Efferth T. Predictive toxicogenomics for phytotherapy. In: Shyur L-F (Ed.) Recent trends in Medicinal Plants Research. Elsevier, Oxford, UK (in press), 2012.
36. Nortier JL, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000; 342: 1686-1692.
37. Arlt VM, Stiborova M and Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis. 2002; 17: 265-277.
38. Kober M, Pohl K and Efferth T. Molecular mechanisms underlying St. John's wort drug interactions. Curr Drug Metab. 2008;9: 1027-1037.
39. Kraft TE, Parisotto D, Schempp C and Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr. 2009; 49: 782-799.
40. Reichling J, Schnitzler P, Suschke U and Saller R. Essential oils of aromatic plants with antibacterial,
antifungal, antiviral, and cytotoxic properties-an overview. Forsch Komplementmed. 2009; 16: 79-90.
41. Astani A, Reichling J and Schnitzler P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother Res. 2010; 24: 673-679.
42. Astani A, Reichling J and Schnitzler P. Screening for Antiviral Activities of Isolated Compounds from Essential Oils. Evid Based Complement Alternat Med. 2012.
43. Pohlit AM, et al. Patent literature on mosquito repellent inventions which contain plant essential oils-a review. Planta Med. 2011; 77: 598-617.
44. Efferth T, Herrmann F, Tahrani A and Wink M. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomedicine. 2011; 18: 959-969.
45. Sertel S, Eichhorn T, Plinkert PK and Efferth T. Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res. 2011; 31: 81-87.
46. Sertel S, Eichhorn T, Plinkert PK and Efferth T. Chemical Composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells. Anticancer Res. 2011; 31: 185-191.
47. Yim VW, Ng AK, Tsang HW and Leung AY. A review on the effects of aromatherapy for patients with depressive symptoms. J Altern Complement Med. 2009; 15: 187-195.
48. Setzer WN. Essential oils and anxiolytic aromatherapy. Nat Prod Commun. 2009; 4: 1305-1316.
49. Hur MH, Lee MS, Kim C, Ernst E. Aromatherapy for treatment of hypertension: a systematic review. J Eval Clin Pract. 2012; 18: 37-41.
50. Tillett J and Ames D. The uses of aromatherapy in women's health. J Perinat Neonatal Nurs. 2010; 24: 238-245.
51. Lee YL, Wu Y, Tsang HW, Leung AY and Cheung WM. A systematic review on the anxiolytic effects of aromatherapy in people with anxiety symptoms. J Altern Complement Med. 2011; 17: 101-108.
52. Smith CA, Collins CT and Crowther CA. Aromatherapy for pain management in labour. Cochrane Database Syst Rev. 2011; 6 : CD009215.
53. Polonio Tand Efferth T. Leishmaniasis: drug resistance and natural products (review). Int J Mol Med. 2008; 22: 277-286.
54. Stoeva S, T Efferth T. Human Cytomegalovirus: Drug resistance and new treatment options using natural products. Molecular Medicine Reports. 2008; 1: 781-785.
55. Gehrig S and Efferth T. Development of drug resistance in Trypanosoma brucei rhodesiense and
Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products
(Review). Int J Mol Med. 2008; 22: 411-419.
56. Gehrig S and Efferth T. Development of drug resistance in Trichomonas vaginalis and its overcoming with natural products. The Open Bioactive Compound Journal .2009; 2: 21-28.
57. Hupfeld J and Efferth T. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products. In Vivo. 2009; 23: 1-6.
58. Turschner S and Efferth T. Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem. 2009; 9: 206-2124.
59. Wohlfarth C and Efferth T. Natural products as promising drug candidates for the treatment of hepatitis B and C. Acta Pharmacol Sin. 2009; 30: 25-30.
60. Bechtle M, Chen S and Efferth T. Neglected diseases caused by bacterial infections. Curr Med Chem. 2010; 17:42-60.
61. Nussbaum K, Honek J, Cadmus CM and Efferth T. Trypanosomatid parasites causing neglected diseases. Curr Med Chem. 2010; 17: 1594-1617.
62. Bamberger D, et al. Fighting mycobacterial infections by antibiotics, phytochemicals and vaccines. MicrobesInfect. 2011; 13: 613-623.
63. Müllner A, et al. Chemistry and pharmacology of neglected helminthic diseases. Curr Med Chem. 2011; 18: 767-789.
64. Schleich K, Nürnberger C, Sobanski A and Efferth T. Vaccination and antiviral treatment of neglected diseases caused by flaviviral infections. Curr Med Chem. 2011; 18: 604-614.
65. Efferth T. Perspectives for globalized natural medicines. Chin J Nat Med. 2011; 9: 1-6.
66. Heubl G. New aspects of DNA-based authentication of Chinese medicinal plants by molecular biological techniques. Planta Med. 2010; 76: 1963-1974.
67. Efferth T, et al. Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese
medicine and Chinese materia medica with activity against tumor cells. Mol Cancer Ther. 2008; 7: 152-161.
68. Sertel S, et al. Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines. Molecules. 2010; 15: 2886-2910.
69. Kuete V and Efferth T. Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy. J Ethnopharmacol. 2011; 137: 752-766.
70. Efferth Tand Greten HJ. Medicinal and Aromatic Plant Research in the 21st Century. Medicinal Aromatic Plants.2012; 1:e110.
71. Ibrahim Singab ANB.Medicinal & Aromatic Plants. Medicinal Aromatic Plants. 2012; 1:e109.
72. Hosni K. Medicinal and Aromatic Plants in Developing Countries. Medicinal Aromatic Plants. 2012; 1:e118.
73. Mamedov N. Medicinal Plants Studies: History, Challenges and Prospective. Med Aromat Plants. 2012; 1:e133.
74. Akerele O. Importance of medicinal plants: WHO’s programme. In: Natural Resources and Human Health: plants of medicinal and nutritional value. Elsevier, Amserdam, Netherlands. 1992; 6377.
75. Farnsworth NR and Soejarto DD. Global importance of medicinal plants. In: Conservation of Medicinal Plants. Cambridge University Press, UK. 1991; 25-52.
76. Padulosi S, Leaman D and Quek P. Challenges and opportunities in enhancing the conservation and use of medicinal and aromatic plants. J Herbs Spices Med Plants. 2002; 9: 243-267
77. De Padula, Bunyapraphatsara LS and Lemmens RHMJ. Plant Resources of South East Asia. PROSEA, Bogor, Indonesia. 1999; 21: 1.
78. Fransworth NR. Preclinical assessment of medicinal plants. Natural Resources and Human Health. Elsevier Science Publishers BV, 1992; 87-91.
79. Moerman DE. Native American Medicinal Plants: An Ethnobotanical Dictionary. Timber Press, Inc, Portland, USA. 2009.
80. Moerman DE. Medicinal Plants of Native America. Research Reports in Ethnobotany, Volume 1, University of Michigan Museum of Anthropolgy, Technical Reports No. 19, Ann Arbor, Michigan. 1986.
81. Shankar K and Liao LP. Traditional systems of medicine. Phys Med Rehabil Clin N Am. 2004; 15: 725-747.
82. Sumner J. The natural history of medicinal plants. Timber Press, Portland, USA. 2000.
83. Balick MJ and Cox PA. Plants, People, and Culture: The Science of Ethnobotny, Scientific American Library. 1997.
84. Zhu YP. Chinese Materia Medica Chemistry, Pharmacology and Applications. CRC Press, Taylor & Francis Group. 1998.
85. Lovkova M, et al.Why do plants cure? Nauka, Moscow, Russia. 1989.
86. Mamedov N and Craker L. Endemic species of Artemisia L. (Asteraceae) from Caspian Sea region as alternative sources for malaria treatment. Proceedings of the First International Medicinal and Aromatic Plants Conference on Culinary Herbs, Antalya, Turkey. Acta Horticulturae. 2008; 826: 277-280.
87. Kilham C. Tales from the Medicine Trail: Tracking Down the Health Secrets of Shamans, Herbalists, Mystics, Yogis, and Other Healers. (1st edn), Rodale Press, PA. 2000.
Pharmacognosy-facts-and-future (pdf)
DownloadCopyright © 2023 Farmers For Health Global Initiative - All Rights Reserved.
Powered by GoDaddy